Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.53 Insider Own1.00% Shs Outstand172.99M Perf Week2.38%
Market Cap4.39B Forward P/E- EPS next Y-0.92 Insider Trans61.28% Shs Float164.32M Perf Month8.22%
Income-210.10M PEG- EPS next Q-0.22 Inst Own71.60% Short Float14.46% Perf Quarter50.83%
Sales2.40M P/S1830.81 EPS this Y-135.30% Inst Trans0.81% Short Ratio9.00 Perf Half Y64.19%
Book/sh0.44 P/B57.73 EPS next Y27.00% ROA-98.60% Target Price36.00 Perf Year181.28%
Cash/sh2.07 P/C12.25 EPS next 5Y- ROE- 52W Range7.17 - 26.48 Perf YTD57.18%
Dividend- P/FCF- EPS past 5Y-44.67% ROI-200.90% 52W High-4.08% Beta1.73
Dividend %- Quick Ratio3.90 Sales past 5Y-37.60% Gross Margin72.70% 52W Low254.25% ATR0.94
Employees138 Current Ratio3.90 Sales Q/Q-61.50% Oper. Margin- RSI (14)64.11 Volatility2.49% 3.81%
OptionableYes Debt/Eq2.78 EPS Q/Q61.10% Profit Margin- Rel Volume0.49 Prev Close25.47
ShortableYes LT Debt/Eq2.78 EarningsAug 08 AMC Payout- Avg Volume2.64M Price25.40
Recom1.50 SMA204.03% SMA5011.18% SMA20053.87% Volume1,287,638 Change-0.27%
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jul-28-11Initiated Summer Street Research Buy $8
Jul-13-11Resumed Brean Murray Buy $8
May-17-11Initiated Oppenheimer Outperform $6
Feb-23-11Initiated Wedbush Outperform $6
Jul-03-07Initiated Brean Murray Buy $8
Feb-20-07Initiated Lazard Capital Buy $6
Jul-11-18 07:35AM  Complimentary Technical Snapshots on Incyte and Three More Biotech Stocks ACCESSWIRE
Jun-27-18 10:42AM  How Financially Strong Is Immunomedics Inc (NASDAQ:IMMU)? Simply Wall St.
Jun-21-18 04:42PM  [$$] Immunomedics Chairman Buys $19M More in Stock Barrons.com
08:20AM  Today's Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Immunomedics ACCESSWIRE
Jun-15-18 11:39AM  Immunomedics Announces Closing of Public Offering of Common Stock GlobeNewswire
Jun-13-18 08:00AM  Immunomedics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-12-18 02:30PM  The Charts of Immunomedics Look Very Bullish Now TheStreet.com
08:47AM  Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate Benzinga
Jun-11-18 04:13PM  Immunomedics Announces Proposed Public Offering of Common Stock GlobeNewswire
03:48PM  After-hours buzz: RH, PLAY and more CNBC
Jun-05-18 08:49AM  Immunomedics (IMMU) Soars: Stock Adds 10.3% in Session Zacks
08:20AM  Today's Research Reports on Stocks to Watch: Genomic Health and Immunomedics ACCESSWIRE
Jun-04-18 04:33PM  Why Fossil Group, Companhia Siderurgica Nacional, and Immunomedics Jumped Today Motley Fool +10.26%
04:32PM  Why A Tie-Up With Clovis Helped This Biotech Spike To An 18-Year High Investor's Business Daily
03:20PM  Why Data at ASCO 2018 Sent Immunomedics Shares Soaring Today Motley Fool
01:18PM  5 Biotech Stocks Moving On ASCO Presentations Benzinga
08:00AM  Immunomedics Provides Business Update at the ASCO 2018 Investor Event GlobeNewswire
Jun-03-18 08:00PM  Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers GlobeNewswire
10:15AM  Immunomedics Reveals Promising Data for Sacituzumab Govitecan in Patients Heavily Pretreated for Metastatic Estrogen Receptor-Positive Breast Cancer GlobeNewswire
Jun-01-18 08:00AM  Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer GlobeNewswire
May-30-18 08:00AM  Immunomedics to Present at Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-21-18 08:00AM  Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration GlobeNewswire
May-18-18 04:03AM  Edited Transcript of IMMU earnings conference call or presentation 9-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-17-18 12:43PM  Immunomedics Inc (NASDAQ:IMMU): Time For A Financial Health Check Simply Wall St. +7.12%
08:00AM  Today's Research Reports on Trending Tickers: Immunomedics and Rite Aid ACCESSWIRE
May-16-18 05:01PM  Immunomedics Announces Promising Data of Sacituzumab Govitecan in Estrogen Receptor-Positive Metastatic Breast Cancer GlobeNewswire
May-09-18 04:24PM  Immunomedics: Fiscal 3Q Earnings Snapshot Associated Press
04:00PM  Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
07:30AM  Analysis: Positioning to Benefit within Entergy, Schneider National, C.H. Robinson Worldwide, PTC Therapeutics, Guess?, and Immunomedics  Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-02-18 12:01PM  Harry Boxers four biotech stocks to watch today MarketWatch
08:00AM  Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018 GlobeNewswire
May-01-18 08:45AM  Immunomedics (IMMU) in Focus: Stock Moves 7.9% Higher Zacks
08:10AM  Todays Research Reports on Stocks to Watch: Heat Biologics and Immunomedics ACCESSWIRE
Apr-25-18 12:15PM  Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
Apr-17-18 10:21AM  When Will Immunomedics Inc (NASDAQ:IMMU) Become Profitable? Simply Wall St.
Apr-13-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Immunomedics ACCESSWIRE
Apr-11-18 08:30AM  Todays Research Reports on Trending Tickers: Neuralstem and Immunomedics ACCESSWIRE
Apr-09-18 08:00AM  Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer GlobeNewswire
Mar-27-18 08:25AM  Todays Research Reports on Trending Tickers: ACADIA Pharmaceuticals and Immunomedics ACCESSWIRE
Mar-05-18 08:00AM  Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-26-18 06:06PM  Edited Transcript of IMMU earnings conference call or presentation 8-Feb-18 10:00pm GMT Thomson Reuters StreetEvents
Feb-15-18 08:00AM  Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference GlobeNewswire
07:30AM  Fennec Pharma (FENC): The Most Likely Acquisition Target in Healthcare with 200-300% Upside? ACCESSWIRE
Feb-14-18 07:30AM  Blog Exposure - FDA Accepts Amicus Therapeutics NDA for Migalastat for Treatment of Fabry Disease ACCESSWIRE
Feb-13-18 03:49PM  8 Companies That Could Disappear by 2019 InvestorPlace
Feb-09-18 05:01AM  Immunomedics reports 2Q loss Associated Press
Feb-08-18 04:15PM  Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
Feb-06-18 08:00AM  Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018 GlobeNewswire
Jan-31-18 08:20AM  New Research: Key Drivers of Growth for Cavco Industries, National Commerce, The Providence Service, Cisco, Immunomedics, and Emergent Biosolutions Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-17-18 07:00AM  Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock InvestorPlace
Jan-11-18 08:00AM  Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer GlobeNewswire
Jan-10-18 08:00AM  Todays Research Reports on Stocks to Watch: Immunomedics, Inc. and Axsome Therapeutics ACCESSWIRE
Jan-08-18 08:30AM  Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million GlobeNewswire
Jan-04-18 08:45AM  Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:34AM  Harry Boxer: These two marijuana stocks are climbing higher MarketWatch
Dec-22-17 11:41AM  ETFs with exposure to Immunomedics, Inc. : December 22, 2017 Capital Cube +6.08%
Dec-21-17 12:23PM  BlackBerry Among Four Stocks Breaking Out Forbes
Dec-13-17 07:02AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Immunomedics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Dec-11-17 01:59PM  ETFs with exposure to Immunomedics, Inc. : December 11, 2017 Capital Cube
Dec-08-17 01:59PM  5 Cheap Biotech Stocks to Snag on the Bounce InvestorPlace
07:45AM  Immunomedics' Data Is Good News for Seattle Genetics, Too Motley Fool
07:16AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : December 8, 2017 Capital Cube
Dec-07-17 08:10AM  Todays Research Reports on Stocks to Watch: Immunomedics and Valeant Pharmaceuticals ACCESSWIRE +16.16%
Dec-06-17 03:58PM  Why Immunomedics, Inc. Is Soaring Today Motley Fool +13.00%
12:10PM  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC) GlobeNewswire
Nov-30-17 02:00PM  ETFs with exposure to Immunomedics, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:04AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017 Capital Cube
Nov-28-17 08:05AM  Immunomedics, Full Study Data to be Presented December 6, 2017, BLA Application as Early as 1Q18 ACCESSWIRE
Nov-27-17 08:05AM  Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-20-17 07:40AM  Featured Company News - Biohaven Pharma Completed Enrollment in First of Two Pivotal Phase-3 Clinical Trials of Rimegepant for Acute Treatment of Migraine ACCESSWIRE
Nov-16-17 08:43AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks +8.11%
Nov-15-17 08:38AM  Immunomedics (IMMU) Jumps: Stock Rises 5.4% Zacks +5.31%
Nov-14-17 04:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-Nov-17 10:00pm GMT Thomson Reuters StreetEvents +5.40%
12:44PM  Cowen Bets on Immunomedics Securing Accelerated Approval Even After Decreased Overall Survival Seen in IMMU-132 Abstract SmarterAnalyst
Nov-13-17 04:30PM  Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today Motley Fool -19.35%
09:30AM  Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium GlobeNewswire
07:24AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : November 13, 2017 Capital Cube
Nov-10-17 03:02PM  Why Immunomedics, Inc. Jumped Higher Today Motley Fool +18.77%
08:20AM  Todays Research Reports on Trending Tickers: Endo International and Immunomedics ACCESSWIRE
Nov-09-17 05:21PM  Immunomedics reports 1Q loss Associated Press
04:10PM  Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
04:05PM  Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth GlobeNewswire
01:00PM  Immunomedics, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 08:00AM  Immunomedics to Report First Quarter Fiscal 2018 Results and Host Conference Call and Webcast on November 9, 2017 GlobeNewswire +6.82%
Oct-31-17 12:13PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : October 31, 2017 Capital Cube -5.13%
11:42AM  ETFs with exposure to Immunomedics, Inc. : October 31, 2017 Capital Cube
Oct-30-17 08:11AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : October 30, 2017 Capital Cube
Oct-27-17 09:35AM  Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers TheStreet.com +6.18%
Oct-23-17 08:37AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Oct-05-17 12:21PM  Edited Transcript of IMMU earnings conference call or presentation 16-Aug-17 9:00pm GMT Thomson Reuters StreetEvents -8.50%
Oct-03-17 11:19AM  ETFs with exposure to Immunomedics, Inc. : October 3, 2017 Capital Cube
Sep-15-17 04:30PM  Why Carnival, Immunomedics, and Fitbit Slumped Today Motley Fool
08:00AM  Immunomedics Announces Agreements to Exchange Approximately $80.0 Million of Its 4.75% Convertible Senior Notes Due 2020 for Common Stock GlobeNewswire
Sep-11-17 09:00AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks +5.17%
07:00AM  Immunomedics Presents Interim Phase 2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Pretreated Metastatic Urothelial Cancer GlobeNewswire
Aug-30-17 08:00AM  Immunomedics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-28-17 05:33PM  ETFs with exposure to Immunomedics, Inc. : August 28, 2017 Capital Cube +14.07%
03:30PM  Here's Why Immunomedics Rose as Much as 14.2% Today Motley Fool
Aug-24-17 12:51PM  Harry Boxer: These three biotech stocks are breaking out MarketWatch +9.88%
10:45AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q4, 2017 By the Numbers : August 24, 2017 Capital Cube
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. The company also provides LeukoScan, a diagnostic imaging product to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody; and a collaboration agreement with University of Wisconsin Carbone Cancer Center to expand IMMU-132 into prostate cancer. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
venBio Select Advisor LLCDirectorJun 15Buy24.00575,00013,800,00017,514,461Jun 15 02:02 PM
venBio Select Advisor LLCDirectorJun 15Buy23.39200,0004,678,00017,714,461Jun 19 04:05 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.6840,000707,0005,613,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.5020,000350,0001,774,285Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 05Sale17.2440,000689,4005,653,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorFeb 28Sale17.0917,729302,9895,693,252Mar 12 08:32 PM
MARKISON BRIAN ADirectorNov 20Option Exercise3.1615,00047,40099,178Nov 21 05:00 PM
MARKISON BRIAN ADirectorNov 20Sale11.898,39099,72490,788Nov 21 05:00 PM
venBio Select Advisor LLCDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 15 05:48 PM
venBio Select Advisor LLCDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 15 05:48 PM
GOLDENBERG CYNTHIA LDirectorSep 01Sale12.9010,000129,000778,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksSep 01Sale12.9010,000129,0003,395,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 31Sale12.3810,000123,750788,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksAug 31Sale12.3810,000123,7503,405,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 28Sale11.5215,000172,841798,219Aug 28 08:54 PM
GOLDENBERG DAVID MSee RemarksAug 28Sale11.5610,000115,5913,415,578Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 24Sale10.2425,000256,105813,219Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 23Sale9.5010,00095,000838,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 23Sale9.5010,00095,0003,455,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 22Sale9.5010,00095,000848,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 22Sale9.5010,00095,0003,465,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 21Sale8.9720,000179,426858,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 21Sale8.9720,000179,4263,475,578Aug 23 09:00 PM
CONN Conn's, Inc. daily Stock Chart
CONN [NASD]
Conn's, Inc.
Index- P/E34.94 EPS (ttm)1.08 Insider Own4.30% Shs Outstand30.11M Perf Week4.74%
Market Cap1.13B Forward P/E12.46 EPS next Y3.02 Insider Trans0.43% Shs Float22.06M Perf Month7.58%
Income34.90M PEG1.40 EPS next Q0.42 Inst Own67.50% Short Float17.57% Perf Quarter31.24%
Sales1.52B P/S0.75 EPS this Y174.10% Inst Trans-0.02% Short Ratio6.99 Perf Half Y8.51%
Book/sh17.43 P/B2.16 EPS next Y34.55% ROA1.20% Target Price43.00 Perf Year82.08%
Cash/sh0.21 P/C182.60 EPS next 5Y25.00% ROE4.10% 52W Range16.55 - 38.40 Perf YTD5.77%
Dividend- P/FCF13.91 EPS past 5Y-16.90% ROI6.10% 52W High-2.08% Beta1.53
Dividend %- Quick Ratio4.10 Sales past 5Y11.90% Gross Margin52.90% 52W Low127.19% ATR1.55
Employees4000 Current Ratio5.10 Sales Q/Q0.70% Oper. Margin8.20% RSI (14)68.39 Volatility4.59% 3.86%
OptionableYes Debt/Eq1.73 EPS Q/Q571.00% Profit Margin1.40% Rel Volume0.68 Prev Close37.20
ShortableYes LT Debt/Eq1.69 EarningsJun 07 BMO Payout0.00% Avg Volume554.59K Price37.60
Recom1.30 SMA207.22% SMA5023.51% SMA20021.24% Volume374,588 Change1.08%
Jul-11-18Upgrade Stifel Hold → Buy $35 → $45
Jun-08-18Reiterated Stifel Hold $30 → $35
Oct-18-17Reiterated KeyBanc Capital Mkts Overweight $24 → $42
Oct-09-17Downgrade Stifel Buy → Hold $26 → $30
Sep-08-17Reiterated Stifel Buy $20 → $26
Jun-07-17Reiterated Stifel Buy $19 → $20
Apr-26-17Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Sep-21-16Upgrade Stifel Hold → Buy $16
Jun-03-16Downgrade Piper Jaffray Overweight → Neutral
Jan-13-16Downgrade Stifel Buy → Hold
Dec-09-15Reiterated Stifel Buy $35 → $32
Dec-01-15Upgrade Stifel Hold → Buy $35
Sep-15-15Downgrade Stifel Buy → Hold
Jun-03-15Reiterated Stifel Buy $43 → $49
May-22-15Reiterated Stifel Buy $35 → $43
May-11-15Reiterated Piper Jaffray Overweight $38 → $45
May-05-15Upgrade Oppenheimer Perform → Outperform $39
Feb-09-15Upgrade Stifel Hold → Buy $33
Dec-10-14Reiterated B. Riley & Co. Buy $62 → $52
Sep-03-14Reiterated Canaccord Genuity Buy $71 → $40
Jul-16-18 01:25PM  4 Top Ranked Growth Stocks to Buy for July 16th InvestorPlace
09:53AM  Top Ranked Growth Stocks to Buy for July 16th Zacks
09:30AM  Is Conn's (CONN) Outperforming Other Retail-Wholesale Stocks This Year? Zacks
Jul-12-18 10:47AM  New Strong Buy Stocks for July 12th Zacks
Jul-11-18 11:16AM  'Dramatic Improvements': Stifel Goes Full Bull On Conn's Benzinga
Jul-10-18 07:30AM  Free Technical Research on GameStop and Three More Services Equities ACCESSWIRE
Jul-09-18 07:10AM  Free Post Earnings Research Report: Conn's Adjusted EPS Outperformed Estimates ACCESSWIRE
Jun-29-18 04:28PM  Edited Transcript of CONN earnings conference call or presentation 7-Jun-18 3:00pm GMT Thomson Reuters StreetEvents
Jun-22-18 01:46PM  What does Conns Incs (NASDAQ:CONN) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-07-18 01:01PM  A Strong First Quarter Sends Conn's Shares 21% Higher Thursday Motley Fool +24.56%
07:28AM  UPDATE: Conn's shares soar 21% premarket after earnings beat MarketWatch
06:08AM  Conn's: Fiscal 1Q Earnings Snapshot Associated Press
06:00AM  Conn's, Inc. Reports First Quarter Fiscal 2019 Financial Results GlobeNewswire
Jun-03-18 12:39PM  Job openings, trade balance What you need to know for the week ahead Yahoo Finance
May-31-18 07:00AM  Conn's, Inc. Schedules Conference Call to Discuss First Quarter Fiscal Year 2019 Results GlobeNewswire
May-30-18 07:10AM  Free Research Reports on Best Buy and Three More Services Stocks ACCESSWIRE
May-24-18 04:30PM  Conn's, Inc. Announces Closing of Amended and Restated $650 Million Credit Facility GlobeNewswire
Apr-27-18 07:40AM  Free Post Earnings Research Report: Conn's Quarterly Earnings Jumped 1020% ACCESSWIRE +6.00%
Apr-25-18 07:50AM  Recent Analysis Shows First Cash, ADTRAN, OMNOVA Solutions, Athersys, Oppenheimer, and Conn's Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-16-18 07:33AM  New Strong Sell Stocks for April 16th Zacks
Apr-15-18 06:05PM  Insider Buys Of The Week: Intercept Pharmaceuticals, Macy's And More Benzinga
Apr-12-18 08:43AM  Falling Earnings Estimates Signal Weakness Ahead for Conn's (CONN) Zacks
Apr-10-18 02:04PM  Can Conn's Stock Bounce Back After Last Week's 19% Drop? Motley Fool
Apr-07-18 02:57PM  Conn's (CONN) Q4 2018 Earnings Conference Call Transcript Motley Fool
Apr-06-18 04:35PM  Why Square, U.S. Steel, and Conn's Slumped Today Motley Fool -9.85%
Apr-05-18 05:15PM  What Happened in the Stock Market Today Motley Fool -14.30%
04:35PM  Deere and Facebook climb while Conn's and Welltower slip Associated Press
12:33PM  Shares of Conn's, Inc. Drop 13% After Mixed Fourth-Quarter Results Motley Fool
08:19AM  Conn's stock tumbles after sales miss, downbeat outlook MarketWatch
06:22AM  Conn's tops 4Q profit forecasts Associated Press
06:00AM  Conn's, Inc. Reports Fourth Quarter Fiscal Year 2018 Financial Results GlobeNewswire
Apr-04-18 07:23PM  Facebook fallout, trade fears What you need to know in markets on Thursday Yahoo Finance
Apr-03-18 03:15PM  Conn's executives see salary increases, equity awards American City Business Journals
Mar-30-18 06:15PM  Are Conns Incs (NASDAQ:CONN) Interest Costs Too High? Simply Wall St.
Mar-29-18 03:01PM  Anatomy of Success: Conn's Inc. (CONN) Zacks +5.10%
10:54AM  Will Conn's (CONN) Strong Retail Business Aid Q4 Earnings? Zacks
Mar-28-18 04:45PM  Conn's, Inc. Schedules Conference Call to Discuss Fourth Quarter Fiscal Year 2018 Results GlobeNewswire
Mar-26-18 09:24AM  4 Stocks to Yield Better Returns as Retail Sales Pick Up Zacks +6.47%
Mar-21-18 09:27AM  Filling the Sweet 16 Brackets With Top-Ranked Stocks Zacks
Mar-14-18 08:40AM  5 Top Stocks to Make the Most of March Madness Zacks
Mar-01-18 01:17PM  L Brands (LB) Beats on Q4 Earnings, Issues FY18 Guidance Zacks
07:40AM  Report: Exploring Fundamental Drivers Behind BWX Technologies, WMIH, Conn's, Athersys, Proofpoint, and Kindred Healthcare New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-22-18 08:40AM  The Zacks Analyst Blog Highlights: Kohl's, Best Buy, Conn's, RH and Walmart Zacks
Feb-13-18 12:59PM  W.R. Grace & Co.-Conn. -- Moody's assigns Ba1 ratings to Grace's new $1.3 billion secured credit facilities Moody's
Jan-19-18 09:12AM  New Strong Buy Stocks for January 19th Zacks
Jan-16-18 08:01PM  Edited Transcript of CONN earnings conference call or presentation 7-Dec-17 4:00pm GMT Thomson Reuters StreetEvents -6.73%
07:49AM  Factors That Make Beacon Roofing (BECN) a Lucrative Bet Now Zacks
Jan-10-18 07:53AM  The Zacks Analyst Blog Highlights: Conn's, Beacon Roofing, McDonald's and Boot Barn Zacks
Jan-09-18 06:59PM  Cramer's lightning round: The analysts downgrading Edward... CNBC Videos
07:40AM  Free Research Report as Conns Q3 Results Outshone Expectations ACCESSWIRE
Jan-04-18 07:30AM  New Research: Key Drivers of Growth for Conn's, Molina Healthcare, Zillow Group, Boston Properties, BWX Technologies, and Penumbra Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-02-18 02:19PM  Stephens' Analysts Present Their Best Ideas For 2018 Benzinga
Dec-29-17 08:30AM  Conn's (CONN): Strong Industry, Solid Earnings Estimate Revisions Zacks
Dec-28-17 07:10AM  Free Post Earnings Research Report: Best Buy's Revenue Grew 4%; EPS Surged 30% ACCESSWIRE
Dec-27-17 04:17PM  Stephens Drops 18 Names From Best Ideas List Before The New Year Benzinga
08:34AM  Retail is Staging a Big Comeback in 2018: 5 Solid Buys Zacks
08:34AM  7 Hot Momentum Stocks to Watch in 2018 Zacks
Dec-26-17 11:23AM  ETFs with exposure to Conns, Inc. : December 26, 2017 Capital Cube
Dec-21-17 08:52AM  Surging Earnings Estimates Signal Good News for Conn's (CONN) Zacks
Dec-20-17 05:00PM  Conn's, Inc. Announces Closing of $669.3 Million Securitization Transaction GlobeNewswire
Dec-13-17 07:30PM  Conn's, Inc. Announces Pricing of Securitization Transaction GlobeNewswire
09:39AM  Top Ranked Momentum Stocks to Buy for December 13th Zacks
Dec-12-17 12:59PM  ETFs with exposure to Conns, Inc. : December 12, 2017 Capital Cube
Dec-11-17 10:42AM  Conns, Inc. :CONN-US: Earnings Analysis: Q3, 2018 By the Numbers : December 11, 2017 Capital Cube -5.71%
Dec-08-17 10:14AM  Company News For Dec 8, 2017 Zacks
08:58AM  Conn's (CONN) in Focus: Stock Moves 6.2% Higher Zacks
Dec-07-17 01:29PM  Shares of Conn's Bounce 16% After 2nd Consecutive Profitable Quarter Motley Fool +6.19%
08:00AM  Conn's, Inc. to Host Earnings Call ACCESSWIRE
06:19AM  Conn's beats Street 3Q forecasts Associated Press
06:00AM  Conn's, Inc. Reports Third Quarter Fiscal Year 2018 Financial Results GlobeNewswire
Dec-06-17 06:12PM  Initial claims, Dollar General What you need to know in markets on Thursday Yahoo Finance
Nov-30-17 05:07PM  Conn's, Inc. Schedules Conference Call to Discuss Third-Quarter Fiscal 2018 Results GlobeNewswire
Nov-27-17 10:42AM  Black Friday 2017: Here Are The Retailers Who Showed Holiday Promise Benzinga
Nov-08-17 02:37PM  7 Large-Cap Stocks With a Potential Financial Dark Side InvestorPlace
Oct-30-17 10:38AM  US GDP Hits 3% Despite Twin Hurricanes: 5 Top Gainers Zacks
10:11AM  Aaron's (AAN) Stock Falls on Q3 Earnings Miss, Revenues Beat Zacks
Oct-26-17 05:00PM  Does Conns Incs (CONN) Debt Level Pose A Serious Problem? Simply Wall St.
10:10AM  Tractor Supply (TSCO) Beats on Q3 Earnings, Raises Guidance Zacks
Oct-25-17 11:12AM  Harry Boxers momentum stocks to watch this week MarketWatch
Oct-24-17 04:30PM  Why Polaris Industries, Corning, and Conn's Jumped Today Motley Fool +16.57%
01:37PM  Shares of Conn's Move 10% Higher After Sales Uptick Motley Fool
12:33PM  3 Stocks Where Shrinking Revenue Is No Big Deal Motley Fool
Oct-23-17 05:24PM  Conn's, Inc. Provides Business Update Post Hurricane Harvey and Third Quarter Guidance GlobeNewswire
Oct-20-17 09:55AM  Conn's, Titan International and PayPal Holdings highlighted as Zacks Bull and Bear of the Day Zacks
07:01AM  Bull of the Day: Conn's Inc. (CONN) Zacks
Oct-12-17 07:49AM  5 Stocks With Strong Earnings Beat Potential Zacks
Oct-10-17 11:12AM  ETFs with exposure to Conns, Inc. : October 10, 2017 Capital Cube
08:47AM  Why You Shouldn't Bet Against Conn's (CONN) Stock Zacks
Oct-09-17 05:17PM  Furniture Stores Show September Stock Gains Motley Fool -6.08%
Oct-06-17 08:38AM  Are Options Traders Betting on a Big Move in Conn's (CONN) Stock? Zacks
Oct-04-17 09:03AM  Zacks.com featured highlights include article EVERTEC, Amphenol, Stanley Black & Decker and Conn's Zacks
Oct-03-17 03:42PM  Can Conn's Stock Keep Going After Last Week's 23% Pop? Motley Fool
Sep-29-17 08:52AM  Conn's stock jumps toward 21-month high after an analyst upgrade MarketWatch +9.75%
08:32AM  Should You Be Concerned About Conns Incs (CONN) Risks? Simply Wall St.
Sep-28-17 07:30AM  Earnings Review and Free Research Report: Conn's Reported Better than Expected Earnings ACCESSWIRE
Sep-27-17 04:07PM  Conn's and Signet are Aggressive Growth Rank Buys Zacks
Sep-26-17 10:46AM  ETFs with exposure to Conns, Inc. : September 26, 2017 Capital Cube
Sep-18-17 08:16AM  Conns HomePlus Introduces National Toy and Book Drive to Support Texas Children Impacted by Hurricane Harvey Business Wire
Sep-16-17 09:20AM  These 3 Stocks Have Doubled Investors' Money Motley Fool
Sep-15-17 08:38AM  Options Traders Expect Huge Moves in Conn's (CONN) Stock Zacks
Conn's, Inc. operates as a specialty retailer of durable consumer goods and related services in the United States. The company operates through two segments, Retail and Credit. Its stores provide furniture and mattress, including furniture and related accessories for the living room, dining room, and bedroom, as well as traditional and specialty mattresses; home appliances, such as refrigerators, freezers, washers, dryers, dishwashers, and ranges; consumer electronics comprising televisions, Blu-ray players, home theaters, and portable audio equipment; and home office products consisting of computers, printers, and accessories. The company also provides short- and medium-term financing to its retail customers; and product support services, such as next-day delivery and installation services, credit insurance products, product repair services, and repair service agreements. As of April 5, 2018, it operated 118 retail locations in Alabama, Arizona, Colorado, Georgia, Louisiana, Mississippi, Nevada, New Mexico, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, and Virginia. Conn's, Inc. was founded in 1890 and is headquartered in The Woodlands, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARTIN BOB LDirectorJul 13Sale37.746,000226,44457,265Jul 17 07:02 PM
Renaud ToddVice President - CIOJun 13Sale36.751,00036,75045,879Jun 14 02:23 PM
MARTIN BOB LDirectorJun 01Option Exercise16.9310,000169,30063,265Jun 01 05:54 PM
MARTIN DOUGLAS HDirectorMay 30Option Exercise16.9310,000169,30027,795Jun 01 02:05 PM
Bchara George LChief Accounting OfficerApr 10Buy27.417,390202,52446,406Apr 12 12:09 PM
Daly BrianChief Human Resources OfficerApr 09Buy27.875,100142,12855,806Apr 10 07:54 PM
Anchorage Capital Group, L.L.C10% OwnerDec 18Sale34.051,600,00054,480,0002,953,958Dec 20 04:51 PM
Schofman DavidDirectorDec 11Buy32.201,00032,19820,384Dec 14 05:27 PM
STEPHENS WARREN A10% OwnerOct 16Buy25.5023,000586,4752,792,920Oct 18 05:42 PM
STEPHENS HARRIET C10% OwnerOct 16Buy25.5023,000586,4752,792,920Oct 18 05:40 PM
STEPHENS WARREN A10% OwnerOct 13Buy25.5012,000306,0222,769,920Oct 16 05:58 PM
STEPHENS HARRIET C10% OwnerOct 13Buy25.5012,000306,0222,769,920Oct 16 05:57 PM
STEPHENS WARREN A10% OwnerOct 12Buy25.3630,000760,7792,757,920Oct 16 05:58 PM
STEPHENS HARRIET C10% OwnerOct 12Buy25.3630,000760,7792,757,920Oct 16 05:57 PM
LPTH LightPath Technologies, Inc. daily Stock Chart
LPTH [NASD]
LightPath Technologies, Inc.
Index- P/E7.88 EPS (ttm)0.31 Insider Own0.80% Shs Outstand25.45M Perf Week6.96%
Market Cap62.61M Forward P/E18.92 EPS next Y0.13 Insider Trans0.00% Shs Float20.80M Perf Month14.42%
Income8.20M PEG- EPS next Q0.02 Inst Own28.30% Short Float7.07% Perf Quarter11.82%
Sales33.40M P/S1.87 EPS this Y324.10% Inst Trans- Short Ratio11.79 Perf Half Y4.24%
Book/sh1.41 P/B1.74 EPS next Y49.43% ROA17.40% Target Price2.72 Perf Year-7.87%
Cash/sh0.25 P/C9.78 EPS next 5Y- ROE25.70% 52W Range1.97 - 4.10 Perf YTD10.81%
Dividend- P/FCF44.72 EPS past 5Y43.40% ROI27.20% 52W High-39.99% Beta-0.73
Dividend %- Quick Ratio2.50 Sales past 5Y20.20% Gross Margin43.20% 52W Low24.87% ATR0.08
Employees321 Current Ratio3.70 Sales Q/Q0.00% Oper. Margin6.20% RSI (14)72.57 Volatility3.76% 3.51%
OptionableNo Debt/Eq0.21 EPS Q/Q1116.30% Profit Margin24.60% Rel Volume1.64 Prev Close2.35
ShortableYes LT Debt/Eq0.16 EarningsAug 13 AMC Payout0.00% Avg Volume124.72K Price2.46
Recom1.70 SMA209.78% SMA5012.93% SMA2002.49% Volume204,547 Change4.80%
Oct-06-17Resumed Dougherty & Company Buy $3.10
May-05-17Reiterated Dougherty & Company Buy $3 → $3.50
Jan-10-17Initiated Dougherty & Company Buy $2.50
Dec-22-16Initiated ROTH Capital Buy $2.50
Jun-28-18 09:00AM  LightPath Technologies Receives $1 Million Order for Infrared Optical Lens Elements ACCESSWIRE
Jun-27-18 08:02AM  Is LightPath Technologies Incs (NASDAQ:LPTH) 22.83% ROE Strong Compared To Its Industry? Simply Wall St.
Jun-26-18 09:00AM  LightPath Technologies Announces Order with New Asian Manufacturing Customer for Original High-tech Infrared Product ACCESSWIRE
Jun-20-18 09:00AM  LightPath Technologies Announces Significant Order for New Chalcogenide BD6 Lenses ACCESSWIRE +6.80%
Jun-18-18 09:00AM  LightPath Technologies Announces Enhanced Chalcogenide Infrared Lens Capabilities ACCESSWIRE
Jun-15-18 08:20AM  Report: Exploring Fundamental Drivers Behind Two Harbors Investments, Fortive, WEC Energy Group, LightPath Technologies, Synchronoss Technologies, and Loma Negra Compania Industrial Argentina S.A. New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-05-18 08:30AM  LightPath Technologies Strengthens Management Team ACCESSWIRE
May-16-18 08:06PM  Edited Transcript of LPTH earnings conference call or presentation 14-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 04:00PM  LightPath Technologies Reports Fiscal 2018 Third Quarter Financial Results ACCESSWIRE
12:00PM  LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Apr-30-18 08:30AM  LightPath Technologies Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for May 14, 2018 ACCESSWIRE
Apr-19-18 08:30AM  New Research Coverage Highlights Barnes & Noble, The Blackstone Group, Hill-Rom, UGI, Fortive, and LightPath Technologies Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-28-18 09:00AM  LightPath Technologies to Exhibit at the Upcoming SPIE Defense and Commercial Sensing Event ACCESSWIRE
Mar-12-18 11:16AM  Edited Transcript of LPTH earnings conference call or presentation 13-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-22-18 08:30AM  LightPath Technologies to Present at 30th Annual ROTH Conference ACCESSWIRE
Feb-13-18 04:00PM  LightPath Technologies Reports 42% Increase in Revenue for Fiscal 2018 Second Quarter Financial Results ACCESSWIRE
12:15PM  LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Feb-09-18 07:45AM  Research Report Identifies Hill-Rom, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Adesto Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-06-18 08:30AM  LightPath Technologies Schedules Fiscal 2018 Second Quarter Financial Results Conference Call for February 13 ACCESSWIRE
Feb-05-18 04:46PM  5 of the Best Stocks Under $10 for 2018 Zacks
Feb-01-18 06:00AM  Avidbank Provides $8.3 Million Credit Facilities to LightPath Technologies Business Wire
Jan-25-18 09:00AM  LightPath Technologies Exhibiting at the World's Largest Photonics Technologies Event, SPIE Photonics West 2018 ACCESSWIRE
Jan-16-18 04:00PM  LightPath Restructures Debt with Net Debt Reduced by 32% ACCESSWIRE
Jan-09-18 08:30AM  LightPath to Participate in Needham Growth Conference on January 17, 2018 in New York ACCESSWIRE
Jan-03-18 10:35AM  LightPath Technologies Receives $5 Million Order for Infrared Optical Lens Elements ACCESSWIRE +5.22%
Dec-29-17 12:18PM  ETFs with exposure to LightPath Technologies, Inc. : December 29, 2017 Capital Cube
Dec-18-17 03:53PM  ETFs with exposure to LightPath Technologies, Inc. : December 18, 2017 Capital Cube
Dec-08-17 01:09PM  ETFs with exposure to LightPath Technologies, Inc. : December 8, 2017 Capital Cube
Dec-07-17 10:06AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q1, 2018 By the Numbers : December 7, 2017 Capital Cube
Dec-06-17 08:30AM  LightPath Technologies Bolsters Automotive Electronics Capabilities ACCESSWIRE
Nov-29-17 08:30AM  LightPath Technologies Expands Manufacturing Facility in Latvia to Accommodate Continued Growth for Infrared Products ACCESSWIRE
Nov-21-17 06:29PM  Should You Expect LightPath Technologies Inc (LPTH) To Continue Delivering An ROE Of 37.47%? Simply Wall St.
Nov-20-17 08:10AM  Recent Analysis Shows Premier, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Ichor Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-10-17 12:40PM  ETFs with exposure to LightPath Technologies, Inc. : November 10, 2017 Capital Cube -22.19%
Nov-09-17 10:51PM  Edited Transcript of LPTH earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
04:00PM  LightPath Technologies Reports 51% Increase in Revenue for Fiscal 2018 First Quarter Financial Results ACCESSWIRE
12:30PM  LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Oct-31-17 10:12AM  Penny Stocks to Watch for November 2017 Investopedia
Oct-27-17 11:03AM  ETFs with exposure to LightPath Technologies, Inc. : October 27, 2017 Capital Cube
Oct-26-17 10:01AM  LightPath Technologies, Inc.: Leads amongst peers with strong fundamentals Capital Cube +8.21%
08:55AM  LightPath Technologies (LPTH) Surges: Stock Moves 14.8% Higher Zacks
Oct-19-17 09:15AM  LightPath Technologies Schedules Fiscal 2018 First Quarter Financial Results Conference Call for November 9 ACCESSWIRE
Oct-17-17 09:50AM  ETFs with exposure to LightPath Technologies, Inc. : October 17, 2017 Capital Cube
Oct-06-17 10:56AM  ETFs with exposure to LightPath Technologies, Inc. : October 6, 2017 Capital Cube
Oct-02-17 07:50AM  Earnings Review and Free Research Report: LightPath Technologies Revenue Soared 90%; EPS Rocketed 1100% ACCESSWIRE
Sep-26-17 10:56AM  ETFs with exposure to LightPath Technologies, Inc. : September 26, 2017 Capital Cube
Sep-19-17 11:45AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q4, 2017 By the Numbers : September 19, 2017 Capital Cube
Sep-18-17 02:59PM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017 Capital Cube
Sep-15-17 07:13PM  LightPath Technologies Up on Earnings Beat GuruFocus.com +8.30%
05:41PM  ETFs with exposure to LightPath Technologies, Inc. : September 15, 2017 Capital Cube
09:40AM  Edited Transcript of LPTH earnings conference call or presentation 14-Sep-17 8:30pm GMT Thomson Reuters StreetEvents
Sep-14-17 04:15PM  LightPath Technologies Reports 117% Increase in Operating Income for Fiscal 2017 Fourth Quarter Financial Results ACCESSWIRE -6.59%
12:00PM  Investor Network: LightPath Technologies, Inc. Class A to Host Earnings Call ACCESSWIRE
Sep-11-17 07:19AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating LightPath Technologies, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -7.06%
Sep-05-17 12:00PM  CORRECTION: LightPath Technologies to Participate in Dougherty & Co. Institutional Investor Conference on September 19, 2017 in Minneapolis ACCESSWIRE
09:00AM  LightPath Technologies to Participate in Dougherty & Co. Institutional Investor Conference on September 20, 2017 in Minneapolis ACCESSWIRE
Aug-10-17 04:05PM  LightPath Technologies Announces Preliminary Results for Fiscal 2017 Fourth Quarter ACCESSWIRE
Aug-01-17 04:52PM  ETFs with exposure to LightPath Technologies, Inc. : August 1, 2017 Capital Cube
Jul-06-17 01:58PM  ETFs with exposure to LightPath Technologies, Inc. : July 6, 2017 Capital Cube
Jun-26-17 09:29AM  LightPath Technologies Added to the Russell Microcap(R) Index Accesswire
Jun-19-17 03:40PM  ETFs with exposure to LightPath Technologies, Inc. : June 19, 2017 Capital Cube +5.64%
Jun-05-17 02:29PM  ETFs with exposure to LightPath Technologies, Inc. : June 5, 2017 Capital Cube
Jun-02-17 09:00AM  LightPath Technologies Exhibiting at the Laser World of Photonics Show Accesswire
May-25-17 12:43PM  ETFs with exposure to LightPath Technologies, Inc. : May 25, 2017 Capital Cube
May-24-17 09:30AM  Zacks.com featured highlights: Anavex Life Sciences, Kinross Gold, LightPath Technologies, MFA Financial and Student Transportation Zacks +5.90%
May-23-17 05:15PM  Explosive Stocks Under $10 Zacks
09:10AM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q3, 2017 By the Numbers : May 23, 2017 Capital Cube
May-18-17 09:30AM  The Zacks Analyst Blog Highlights: Applied Optoelectronics, MKS Instruments, Ultra Clean Holdings, Ichor Holdings and LightPath Technologies Zacks
09:00AM  LightPath Technologies Joins the Center of Freeform Optics Accesswire
May-05-17 01:00PM  LightPath Technologies Schedules 2018 Annual Stockholders' Meeting Accesswire -8.56%
May-04-17 04:00PM  LightPath Technologies Reports 500% Increase in Operating Income for Fiscal 2017 Third Quarter Financial Results Accesswire
09:45AM  Investor Network: LightPath Technologies, Inc. to Host Earnings Call Accesswire
Apr-26-17 11:05AM  LightPath Technologies Schedules Fiscal 2017 Third Quarter Financial Results Conference Call for May 4 Accesswire
Apr-24-17 02:35PM  ETFs with exposure to LightPath Technologies, Inc. : April 24, 2017 Capital Cube
Apr-20-17 09:00AM  LightPath Technologies Signs Joint Development Agreement to Produce Fiber Delivery Systems for Autonomous Vehicle Applications with OLE Accesswire +10.04%
Apr-06-17 09:00AM  LightPath Technologies Wins Large Precision Molded Glass Optics Contract from Renishaw Accesswire
Mar-30-17 11:37AM  LightPath Technologies, Inc.: Leads amongst peers with strong fundamentals Capital Cube +14.89%
09:00AM  LightPath Technologies Introduces Chalcogenide Glass Production Accesswire
Mar-09-17 09:00AM  LightPath Technologies to Exhibit at the Upcoming SPIE Defense and Commercial Sensing Event Accesswire
Mar-08-17 01:35PM  LightPath Technologies, Inc. :LPTH-US: Earnings Analysis: Q2, 2017 By the Numbers : March 8, 2017 Capital Cube
Feb-23-17 08:30AM  LightPath Technologies to Present at 29th Annual ROTH Conference Accesswire
Feb-18-17 01:04PM  LIGHTPATH TECHNOLOGIES INC Financials
Feb-15-17 11:47AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition -5.45%
07:09AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
Feb-14-17 03:26PM  LightPath Technologies Reports 119% Increase in Operating Income for Fiscal 2017 Second Quarter Financial Results Accesswire +27.54%
Feb-06-17 11:00AM  LightPath Technologies Schedules Fiscal 2017 Second Quarter Financial Results Conference Call for February 14 Accesswire
Jan-30-17 06:03AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Dis
Jan-17-17 03:59PM  Weekly CFO Buys Highlights GuruFocus.com
Jan-10-17 06:26AM  Coverage initiated on LightPath by Dougherty & Company
Jan-05-17 06:00AM  Avidbank Expands LightPath Technologies Credit Facilities with a $5 Million Acquisition Term Loan Business Wire
Jan-01-17 06:28PM  Weekly CFO Buys Highlight GuruFocus.com
Dec-28-16 03:24PM  LightPath Technologies, Inc.: Gathering momentum, can it sustain its performance? Capital Cube
Dec-27-16 04:30PM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition +11.03%
Dec-22-16 01:44PM  ETFs with exposure to LightPath Technologies, Inc. : December 22, 2016 +9.23%
Dec-21-16 02:07PM  LightPath Technologies Completes Acquisition of ISP Optics Corporation Marketwired
Dec-20-16 04:38PM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St
Dec-16-16 08:45AM  LightPath Technologies Prices Underwritten Public Offering of Class A Common Stock Marketwired +6.56%
Dec-07-16 09:01AM  LIGHTPATH TECHNOLOGIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD Dis
08:30AM  LightPath Technologies Announces Results of Special Meeting of Stockholders Marketwired
Dec-06-16 12:35PM  ETFs with exposure to LightPath Technologies, Inc. : December 6, 2016
LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, GRADIUM glass lenses, and other optical materials used to produce products that manipulate light. Its products are used in various industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries. The company sells its products directly to customers in North America, Europe, and China, as well as through distributors and channel partners in the United States and internationally. LightPath Technologies, Inc. was founded in 1985 and is headquartered in Orlando, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GAYNOR JOSEPH J JRPresident and CEOMay 30Option Exercise0.8713,00011,310148,987May 30 09:57 AM
GAYNOR JOSEPH J JRPresident and CEOJan 22Option Exercise2.1030,00063,000135,987Jan 22 10:24 AM
RIPP ROBERTDirectorDec 27Option Exercise1.8630,00055,800723,751Dec 28 11:14 AM
GAYNOR JOSEPH J JRPresident and CEONov 06Option Exercise3.0515,00045,750107,709Nov 07 10:35 AM
VSTM Verastem, Inc. daily Stock Chart
VSTM [NASD]
Verastem, Inc.
Index- P/E- EPS (ttm)-1.83 Insider Own6.17% Shs Outstand67.69M Perf Week3.85%
Market Cap548.29M Forward P/E- EPS next Y-0.99 Insider Trans0.26% Shs Float67.69M Perf Month24.04%
Income-75.80M PEG- EPS next Q-0.34 Inst Own20.40% Short Float10.80% Perf Quarter94.24%
Sales- P/S- EPS this Y-79.10% Inst Trans4.15% Short Ratio2.89 Perf Half Y170.00%
Book/sh0.76 P/B10.66 EPS next Y20.40% ROA-107.10% Target Price12.33 Perf Year126.26%
Cash/sh0.95 P/C8.54 EPS next 5Y1.74% ROE-163.60% 52W Range2.77 - 9.07 Perf YTD163.84%
Dividend- P/FCF- EPS past 5Y-0.70% ROI- 52W High-10.69% Beta2.58
Dividend %- Quick Ratio4.40 Sales past 5Y- Gross Margin- 52W Low192.42% ATR0.56
Employees69 Current Ratio4.40 Sales Q/Q- Oper. Margin- RSI (14)64.27 Volatility6.45% 8.00%
OptionableYes Debt/Eq0.39 EPS Q/Q-17.80% Profit Margin- Rel Volume0.70 Prev Close8.24
ShortableYes LT Debt/Eq0.39 EarningsAug 07 AMC Payout- Avg Volume2.53M Price8.10
Recom1.80 SMA206.42% SMA5030.98% SMA20091.66% Volume1,781,643 Change-1.70%
Jul-13-18Initiated BTIG Research Buy $17
May-02-18Initiated Seaport Global Securities Buy $14
Mar-08-18Initiated B. Riley FBR, Inc. Buy $15
Sep-07-17Reiterated H.C. Wainwright Buy $6.50 → $10
Apr-13-17Initiated Oppenheimer Outperform
Mar-24-17Reiterated H.C. Wainwright Buy $5 → $6.50
Sep-29-15Downgrade Raymond James Strong Buy → Outperform
Sep-29-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Sep-29-15Downgrade Jefferies Buy → Hold
Sep-29-15Downgrade Cantor Fitzgerald Buy → Hold
Sep-28-15Downgrade ROTH Capital Buy → Neutral $23 → $2
Sep-28-15Downgrade Mizuho Buy → Neutral $21 → $2
Sep-09-15Initiated Raymond James Strong Buy
May-12-15Reiterated UBS Buy $30 → $24
Apr-08-15Initiated H.C. Wainwright Buy $16
Jan-23-15Reiterated ROTH Capital Buy $29 → $23
Jul-08-14Resumed Oppenheimer Perform
Feb-11-14Initiated Mizuho Buy $21
Aug-07-13Reiterated UBS Buy $20 → $30
Jul-12-13Reiterated Oppenheimer Outperform $16 → $18
Jul-13-18 08:00AM  Upcoming Catalysts Could Send This Unknown Stock Up 300% or More ACCESSWIRE +5.46%
Jul-06-18 07:45AM  Complimentary Technical Snapshots on Verastem and Three More Biotech Stocks ACCESSWIRE
Jul-05-18 04:05PM  Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jul-02-18 07:00AM  Verastem Oncology to Participate in the Oppenheimer Boston Oncology Insight Summit Business Wire
Jun-25-18 07:00AM  Verastem Oncology to Join Russell 3000® Index Business Wire
Jun-22-18 10:30AM  Biotech's Making Great Progress ACCESSWIRE
Jun-20-18 08:00AM  Verastem Upcoming FDA Review, Big Steps Forward in the Oncology Space ACCESSWIRE
Jun-19-18 08:08AM  Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares Benzinga
Jun-18-18 10:20AM  Why Verastem's Stock Is Bolting Higher Today Motley Fool +31.39%
10:00AM  Cancer Stem Cell Company, PPCB Flies Under the Radar ACCESSWIRE
08:20AM  Today's Research Reports on Trending Tickers: Verastem and Nektar Therapeutics ACCESSWIRE
Jun-17-18 04:17PM  2 Clinical-Stage Biotech Stocks That Could Soar Next Week Motley Fool
Jun-16-18 06:30AM  Verastem Oncology Presents Duvelisib Data at EHA 2018 Annual Meeting Business Wire
Jun-15-18 04:35PM  Why Verastem Stock Rocketed Higher Today Motley Fool +17.03%
12:13PM  Is There An Opportunity With Verastem Incs (NASDAQ:VSTM) 36% Undervaluation? Simply Wall St.
09:13AM  Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug Benzinga
08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within Companhia Brasileira de Distribuicao, SiteOne Landscape Supply, UGI, Versum Materials, Verastem, and Tanger Factory Outlet Centers New Research Emphasizes Economic Growth GlobeNewswire
08:20AM  Today's Research Reports on Trending Tickers: INSYS Therapeutics and Verastem ACCESSWIRE
Jun-14-18 04:03PM  Verastem Oncology Announces $43.0 Million Offering of Common Stock Business Wire
Jun-05-18 09:14AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +7.39%
08:05AM  Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index Benzinga
07:46AM  Market Sentiment Around Loss-Making Verastem Inc (NASDAQ:VSTM) Simply Wall St.
07:40AM  Complimentary Technical Snapshots on Viking Therapeutics and Three More Biotech Stocks ACCESSWIRE
03:00AM  Verastem Oncology and Yakult Honsha Co., Ltd. Sign Exclusive License Agreement for the Development and Commercialization of Duvelisib in Japan Business Wire
Jun-04-18 04:05PM  Verastem Oncology Presents Data on Two Lead Drug Candidates at ASCO 2018 Annual Meeting Business Wire
07:00AM  Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
May-25-18 08:30AM  Today's Research Reports on Trending Tickers: Corcept Therapeutics and Verastem ACCESSWIRE -6.11%
May-23-18 04:05PM  Verastem Oncology Announces Closing of Underwriters Option to Purchase Additional Shares Business Wire
May-21-18 04:05PM  Verastem Oncology to Present Scientific Data Supporting Immuno-Oncology Applications of Duvelisib & Defactinib at the 3rd Annual Advances in Immuno-Oncology Congress Business Wire
May-17-18 09:50AM  Verastem Oncology to Present Duvelisib Data at EHA 2018 Annual Meeting Business Wire
May-16-18 05:09PM  Verastem Oncology to Present Data on Two Lead Drug Candidates at ASCO 2018 Annual Meeting Business Wire -12.02%
12:48PM  Why Verastem Stock Is Plunging Today Motley Fool
09:29AM  Verastem Oncology Announces Pricing of Public Offering of Common Stock Business Wire
08:10AM  Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings Benzinga
May-15-18 04:01PM  Verastem Oncology Announces Public Offering of Common Stock Business Wire
May-04-18 04:05PM  Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
May-03-18 05:27PM  Verastem: 1Q Earnings Snapshot Associated Press
04:05PM  Verastem Oncology Reports First Quarter 2018 Financial Results Business Wire
07:00AM  Verastem Oncology Reports on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma Opportunity, Landscape and Advancements in Pre-Commercial Initiatives at Analyst and Investor Day Business Wire
May-02-18 11:56AM  Boston biotech entrepreneur Christoph Westphal launches new startup American City Business Journals
Apr-23-18 07:00AM  Verastem to Host Analyst and Investor Day on May 2, 2018 Business Wire
Apr-19-18 08:00AM  Analysis: Positioning to Benefit within Verastem, DineEquity, Olin, Quantum, Kimco Realty, and NovoCure Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Apr-13-18 08:37AM  Verastem (VSTM) in Focus: Stock Moves 8% Higher Zacks
Apr-09-18 04:05PM  Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire +10.81%
11:10AM  Biotech shares soar on dealmaking, drug breakthroughs; AveXis jumps 77 percent CNBC
08:44AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
03:00AM  FDA Accepts New Drug Application for Duvelisib and Grants Priority Review Business Wire
Mar-29-18 07:00AM  Verastem to Present at the H.C. Wainwright Global Life Sciences Conference Business Wire
Mar-16-18 06:36PM  Infinity (INFI) Reports Narrower-than-Expected Loss in Q4 Zacks
Mar-14-18 04:05PM  Verastem Updates Presentation Time for Oppenheimer & Co. Healthcare Conference Business Wire
07:00AM  Verastem to Present at Upcoming Conferences Business Wire
Mar-13-18 07:00AM  Verastem Reports Year-End 2017 Financial Results Business Wire -5.35%
Mar-02-18 04:05PM  Verastem Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Feb-26-18 07:00AM  Verastem to Present at the 30th Annual ROTH Conference Business Wire
Feb-09-18 07:35AM  Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
07:10AM  Blog Exposure - Verastem Reported Submission of NDA For Duvelisib for Treatment of Patients with Relapsed or Refractory CLL/SLL and Follicular Lymphoma ACCESSWIRE
Feb-07-18 08:30AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  Verastem Submits New Drug Application to U.S. FDA for Duvelisib for the Treatment of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma Business Wire
Feb-06-18 04:05PM  Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-26-18 02:45PM  Verastem Presents Preclinical Data at ASCO-SITC Highlighting the Synergistic Effects of Duvelisib in Combination with Immune Checkpoint or Co-Stimulatory Antibodies in B Cell Lymphoma Model Business Wire +5.26%
Jan-04-18 04:01PM  Verastem Announces Increased Hercules Debt Facility Business Wire
07:01AM  Verastem Appoints Joseph Lobacki as Chief Commercial Officer Business Wire
Dec-15-17 09:18AM  Verastem Announces Pricing of Public Offering of Common Stock Business Wire -13.97%
07:00AM  3 Stocks to Watch on Friday: DDR Corp (DDR), Hess Corp. (HES) and Verastem Inc (VSTM) InvestorPlace
Dec-14-17 05:07PM  Verastem Announces Public Offering of Common Stock Business Wire
Dec-12-17 08:20AM  Todays Research Reports on Trending Tickers: Array BioPharma and Verastem, Inc. ACCESSWIRE
Dec-11-17 05:00PM  Verastem Announces the Presentation of Phase 1 Duvelisib Combination Data in T-Cell Lymphomas at the ASH 2017 Annual Meeting Business Wire -16.86%
12:07PM  2 Biotech Stocks to Have On Your Radar Into the New Year ACCESSWIRE
07:35AM  Verastem Jumps on Leukemia Drug Study Results Investopedia
Dec-10-17 04:30PM  Verastem Announces Clinical Data from the Pivotal Phase 3 DUO Study: Duvelisib Significantly Improves Progression Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Business Wire
Dec-05-17 07:00AM  Verastem to Present Results from Pivotal Phase 3 DUO Study in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at a Research and Development Event at ASH 2017 Business Wire
Nov-20-17 08:39AM  Options Traders Expect Huge Moves in Verastem (VSTM) Stock Zacks +5.54%
07:55AM  Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-08-17 07:00AM  Verastem to Present at Upcoming Investor Conferences Business Wire
Nov-07-17 07:05AM  Verastem reports 3Q loss Associated Press -5.07%
07:00AM  Verastem Reports Third Quarter 2017 Financial Results Business Wire
Nov-02-17 07:30AM  Corporate News Blog - Verastem Announces Plans to Submit NDA Requesting Full Approval of Duvelisib for Treatment of Patients with Relapsed or Refractory CLL/SLL ACCESSWIRE
Nov-01-17 09:25AM  Verastem Announces Data from Phase 3 DUO Study Selected for Oral Presentation at the American Society of Hematology 2017 Annual Meeting Business Wire -9.16%
Oct-31-17 07:00AM  Verastem Announces Regulatory Strategy for Duvelisib New Drug Application Following Guidance from FDA Business Wire
Oct-17-17 07:00AM  Verastem Pays Milestone Payment to Infinity Pharmaceuticals Business Wire
Oct-11-17 04:01PM  Verastem Appoints NgocDiep Le, MD, PhD as Chief Medical Officer Business Wire
Sep-22-17 07:15AM  Verastem to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-07-17 08:00AM  Today's Research Reports on Stocks to Watch: Moleculin Biotech and Verastem ACCESSWIRE
Sep-06-17 11:11AM  Verastem Shares Are Exploding 50% -- Here's Why TheStreet.com +28.13%
10:31AM  Verastem's blood cancer drug succeeds in late-stage trial Reuters
06:15AM  Verastem's blood cancer drug succeeds in late-stage trial Reuters
06:05AM  Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma Business Wire
06:01AM  Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO Study in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Business Wire
Aug-18-17 09:00AM  Implied Volatility Surging for Verastem (VSTM) Stock Options Zacks
Aug-08-17 04:05PM  Verastem Reports Second Quarter 2017 Financial Results Business Wire
Jul-25-17 07:00AM  Verastem Publishes Scientific Data Highlighting Potential Role of FAK Inhibition in Pancreatic and Breast Cancer Business Wire
Jul-13-17 08:10AM  Today's Research Reports on Stocks to Watch: Alder BioPharmaceuticals Inc. and Verastem Inc. Accesswire
Jul-11-17 04:05PM  Verastem Names Julie B. Feder as Chief Financial Officer Business Wire +16.23%
Jul-07-17 08:20AM  Verastem (VSTM) Shows Strength: Stock Adds 42% in Session Zacks
Jun-24-17 10:00AM  Verastem Reports Phase 2 Long-Term Follow-Up Data for Duvelisib in Patients with Double-Refractory Follicular Lymphoma and Small Lymphocytic Lymphoma at the 22nd Congress of the European Hematology Association Business Wire
Jun-07-17 04:05PM  Verastem to Present Long-Term Follow-Up Data from the DYNAMO Study at the 14th International Conference on Malignant Lymphoma Business Wire
Jun-05-17 01:48PM  Notes From ASCO 2017: Tesaro, Amgen, Others Report New Data Benzinga
May-31-17 07:00AM  Verastem to Present at the Jefferies 2017 Global Healthcare Conference Business Wire -11.97%
May-18-17 06:44AM  Verastem Announces Duvelisib Data Presentations at the 22nd Congress of the European Hematology Association Business Wire
May-11-17 08:00AM  Today's Research Reports on Stocks to Watch: Array Biopharma and Verastem Accesswire
Verastem, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K) signaling pathways. The company's lead FAK inhibitor is defactinib, an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. Its defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. The company also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with hematologic cancers through the dual inhibition of PI3K delta and gamma. Its duvelisib is in Phase 3 randomized and late-and mid-stage clinical trials for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, as well as completed the Phase 2 study for the treatment of patients with double-refractory indolent non-Hodgkin lymphoma. The company has license agreements with Infinity Pharmaceuticals, Inc.; and Pfizer, Inc. Verastem, Inc. was founded in 2010 and is headquartered in Needham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bloom Steven H.Chief Strategy OfficerJun 08Buy5.983,00017,9403,500Jun 12 06:58 PM
Lobacki Joseph MExecutive VP & CCOJun 08Buy5.797,70044,5837,700Jun 12 06:58 PM
BARBERICH TIMOTHY JDirectorDec 05Buy3.9560,538239,125130,000Dec 07 04:02 PM
HPJ Highpower International, Inc. daily Stock Chart
HPJ [NASD]
Highpower International, Inc.
Index- P/E3.50 EPS (ttm)0.85 Insider Own32.69% Shs Outstand16.09M Perf Week-7.38%
Market Cap47.69M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.47M Perf Month-12.83%
Income13.10M PEG- EPS next Q- Inst Own12.90% Short Float0.77% Perf Quarter-15.32%
Sales252.10M P/S0.19 EPS this Y168.40% Inst Trans- Short Ratio1.93 Perf Half Y-29.43%
Book/sh4.46 P/B0.66 EPS next Y- ROA6.10% Target Price12.86 Perf Year-26.82%
Cash/sh1.17 P/C2.52 EPS next 5Y- ROE20.90% 52W Range2.75 - 5.89 Perf YTD-19.89%
Dividend- P/FCF- EPS past 5Y53.80% ROI10.00% 52W High-49.72% Beta2.65
Dividend %- Quick Ratio0.70 Sales past 5Y16.70% Gross Margin17.90% 52W Low7.78% ATR0.11
Employees3600 Current Ratio1.00 Sales Q/Q18.90% Oper. Margin5.30% RSI (14)44.02 Volatility3.75% 3.11%
OptionableYes Debt/Eq1.37 EPS Q/Q-143.50% Profit Margin5.20% Rel Volume0.39 Prev Close3.00
ShortableYes LT Debt/Eq0.00 EarningsAug 10 BMO Payout0.00% Avg Volume41.94K Price2.96
Recom- SMA20-5.10% SMA50-5.69% SMA200-23.24% Volume16,387 Change-1.20%
Sep-29-14Reiterated H.C. Wainwright Buy $8 → $12
Sep-23-14Initiated Ardour Capital Buy $15
May-13-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $4
Mar-31-10Reiterated Rodman & Renshaw Mkt Outperform $5 → $7
Aug-17-09Initiated Rodman & Renshaw Mkt Outperform $5
Jun-26-18 10:44AM  What does Highpower International Incs (NASDAQ:HPJ) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-25-18 08:30AM  Highpower International Announces Formation of Special Committee PR Newswire
Jun-04-18 08:30AM  Highpower International Announces Receipt of Preliminary Non-Binding "Going Private" Proposal from its Chief Executive Officer at $4.80 per share PR Newswire +18.26%
May-11-18 07:00AM  Highpower International Reports Unaudited First Quarter 2018 Financial Results PR Newswire -11.11%
May-09-18 08:30AM  Highpower International to Announce First Quarter 2018 Financial Results PR Newswire
Apr-02-18 07:00AM  Highpower International, Inc. to Host Earnings Call ACCESSWIRE -5.33%
07:00AM  Highpower International Reports Unaudited Fourth Quarter and Full Year 2017 Financial Results PR Newswire
Mar-28-18 11:22AM  /C O R R E C T I O N -- Highpower International, Inc./ PR Newswire
Mar-12-18 08:30AM  Highpower International Preliminary Unaudited 2017 Fourth Quarter and Year End Financial Results PR Newswire +6.49%
Mar-06-18 08:00AM  Highpower International to Participate in the 30th Annual ROTH Conference in California PR Newswire
Dec-28-17 08:30AM  Highpower International to Attend CES 2018 PR Newswire
Dec-15-17 08:30AM  Highpower International Announces Signing of USD $14.2 Million Investment to Ganzhou Highpower PR Newswire
Dec-05-17 08:30AM  Highpower International to Participate in the 5th Annual ROTH Industrial Growth and Cleantech 1x1 Event in New York PR Newswire
Nov-14-17 06:50AM  Highpower International, Inc. to Host Earnings Call ACCESSWIRE -12.27%
06:29AM  Does Highpower International Incs (HPJ) PE Ratio Warrant A Buy? Simply Wall St.
06:00AM  Highpower International Reports Unaudited Third Quarter, First Nine Months 2017 Financial Results PR Newswire
Nov-02-17 08:30AM  Highpower International to Announce Third Quarter 2017 Financial Results PR Newswire
Oct-18-17 08:30AM  Highpower International Announces New Independent Director PR Newswire +5.43%
Oct-10-17 09:20AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2017 By the Numbers : October 10, 2017 Capital Cube +6.93%
Sep-13-17 08:30AM  Highpower International Adopts Stockholder Rights Plan PR Newswire
Sep-05-17 08:30AM  Highpower International to Present at the Rodman & Renshaw 19th Annual Global Investment Conference PR Newswire
Aug-10-17 08:30AM  Investor Network: Highpower International, Inc. to Host Earnings Call ACCESSWIRE -5.05%
06:00AM  Highpower International Reports Unaudited Second Quarter First Half 2017 Financial Results PR Newswire
Aug-07-17 08:30AM  Highpower International to Announce Second Quarter 2017 Financial Results PR Newswire +5.43%
Jul-28-17 08:30AM  Highpower International Receives $10.5 Million from Yipeng Shares Transfer and Enters Strategic Power Cell Supply Agreement with Yipeng PR Newswire
Jul-19-17 04:05PM  Highpower International Announces Preliminary Unaudited Second Quarter 2017 Results PR Newswire
Jul-14-17 08:00AM  Highpower International Enters Smart Vacuum Market with Two New Partnerships PR Newswire +11.59%
Jun-22-17 03:01PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q1, 2017 By the Numbers : June 22, 2017 Capital Cube
Jun-15-17 05:04PM  Highpower International Announces Management Changes PR Newswire +6.67%
Jun-02-17 08:00AM  Highpower International to Present at the 2017 Marcum Microcap Conference PR Newswire
May-10-17 08:45AM  Investor Network: Highpower International, Inc. to Host Earnings Call Accesswire
06:00AM  Highpower International Reports Unaudited First Quarter 2017 Financial Results PR Newswire
May-05-17 08:00AM  Highpower International Enters into Equity Transfer Agreement PR Newswire
May-02-17 08:00AM  Highpower International to Announce First Quarter 2017 Financial Results PR Newswire
Apr-18-17 08:00AM  Highpower International to Attend the SNEC 11th (2017) International Photovoltaic Power Generation Conference & Exhibition PR Newswire +8.74%
Apr-11-17 01:35PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q4, 2016 By the Numbers : April 11, 2017 Capital Cube
10:45AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: 2016 By the Numbers : April 11, 2017 Capital Cube
08:00AM  Highpower International Retains ICR, Inc. PR Newswire
Apr-06-17 03:44PM  6 Stocks Trading Below Peter Lynch Value GuruFocus.com +14.29%
Apr-01-17 01:04PM  HIGHPOWER INTERNATIONAL, INC. Financials
Mar-28-17 09:59AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +30.67%
07:00AM  Highpower International Reports Record Financial Results For the Fourth Quarter and Year End December 31, 2016 PR Newswire
Mar-10-17 05:09PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure
Mar-07-17 02:50PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +6.00%
08:00AM  Highpower International Announces Preliminary Unaudited 2016 Fourth Quarter and Year End Financial Results Highlighted by Significantly Improved Revenues and Net Income PR Newswire
Feb-27-17 08:00AM  Highpower International to Present at the 29th Annual ROTH Growth Conference on March 14, 2017 PR Newswire
Feb-15-17 03:06PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
08:00AM  Highpower International Appointment of Mr. Sunny Pan as Chief Financial Officer Mr. Pan Has Served as Interim CFO since August 2016 PR Newswire
Dec-21-16 02:33PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-14-16 11:49AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Capital Cube
11:49AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
Nov-10-16 09:01AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
Nov-09-16 04:05PM  Highpower International Reports Financial Results For the Third Quarter and Nine Months Ended September 30, 2016 PR Newswire
07:07AM  Q3 2016 Highpower International Inc Earnings Release - After Market Close
Nov-07-16 07:00AM  Highpower International Schedules 2016 Third Quarter Financial Results and Conference Call on November 10, 2016 PR Newswire
Sep-01-16 11:04AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +19.11%
Aug-16-16 10:00AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 Capital Cube
10:00AM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
Aug-15-16 05:30PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
Aug-12-16 07:31AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo +5.24%
07:07AM  Q2 2016 Highpower International Inc Earnings Release - Before Market Open
07:01AM  Highpower International Enters Into Equity Purchase Agreement PR Newswire
07:00AM  Highpower International Reports Financial Results For the Second Quarter And Six Months Ended June 30, 2016 PR Newswire
Aug-09-16 04:29PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
04:05PM  Highpower International Announces Chief Financial Officer Transition PR Newswire
Aug-02-16 08:30AM  Highpower International Schedules 2016 Second Quarter Financial Results and Conference Call on August 12, 2016 PR Newswire
Jul-29-16 08:30AM  Highpower Announces Shipment of Portable Power Stations to Fry's Electronics; Available in Stores in September 2016 PR Newswire
Jun-16-16 08:30AM  Highpower International to Attend Electric Energy Storage Europe on June 22 -24, 2016 PR Newswire
Jun-01-16 12:15PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-16-16 12:55PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-Q, Quarterly Report
May-12-16 09:46AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:30AM  Highpower International Reports Financial Results For the First Quarter Ended March 31, 2016 PR Newswire
07:07AM  Q1 2016 Highpower International Inc Earnings Release - Before Market Open
May-06-16 08:30AM  Highpower International Schedules 2016 First Quarter Financial Results and Conference Call on May 12, 2016 PR Newswire
Apr-12-16 12:04PM  Top Penny Stocks: Four Trending Small Cap Stocks on Tuesday April 12 Accesswire
11:55AM  Heres Why These 5 Stocks Are on the Move Today at Insider Monkey
10:49AM  Recent Analyst Ratings and Fundamental Analysis (NASDAQ: HPJ) Accesswire
10:44AM  Top 4 Stocks The We've Been Watching This Month Accesswire
08:30AM  Highpower International Starts Shipments of Lithium Polymer Batteries to DJI for Use on Its Drone Products PR Newswire
Mar-29-16 05:11PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 10-K, Annual Report
01:22PM  Highpower International, Inc. :HPJ-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-24-16 08:16AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:00AM  Highpower International Reports Financial Results for the Fiscal Fourth Quarter and Year Ended December 31, 2015 PR Newswire
07:07AM  Q4 2015 Highpower International Inc Earnings Release - Before Market Open
Mar-15-16 08:30AM  Highpower International Schedules 2015 Fourth Quarter and Year-End Financial Results and Conference Call on March 24, 2016 PR Newswire
Jan-11-16 08:30AM  Highpower Special Committee Engages Financial Advisor and Legal Counsel PR Newswire
Jan-05-16 08:30AM  Highpower to Exhibit at 2016 International CES in Las Vegas on January 6-9, 2016 PR Newswire
Dec-11-15 10:47AM  Highpower International, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-03-15 05:30PM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-30-15 10:10AM  Company News for November 30, 2015
06:01AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-27-15 11:57AM  These 4 Stocks Are Strong Gainers On Friday at Insider Monkey
08:30AM  Highpower International Announces Receipt of Non-binding Investment Proposal PR Newswire
Nov-16-15 08:30AM  Highpower International to Participate in the Fourth China-Germany Joint Working Group Meeting on Electric Vehicle Battery Recycling PR Newswire
Nov-12-15 08:31AM  HIGHPOWER INTERNATIONAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo
08:00AM  Highpower International Reports Financial Results For the Third Quarter and Nine Months Ended September 30, 2015 PR Newswire
Nov-02-15 08:30AM  Highpower International To Hold Annual Shareholder Meeting on November 28, 2015 PR Newswire
Sep-21-15 11:27AM  Highpower International, Inc. Earnings Q2, 2015
Sep-01-15 08:00AM  MicroCap Review Magazine Summer/Fall 2015 Issue Now Available Marketwired
Aug-31-15 08:30AM  Highpower International to Present at Investor Conferences in September in New York PR Newswire
Highpower International, Inc., together with its subsidiaries, produces and sells nickel-metal hydride (Ni-MH) rechargeable batteries. The company operates in three segments: Lithium Business, Ni-MH Batteries and Accessories, and New Material. It offers Ni-MH rechargeable batteries in AA, AAA, 9V, C, D, and SC sizes in blister packing, as well as chargers and battery packs. The company also provides lithium-ion cylindrical and polymer rechargeable batteries, and power source solutions. In addition, it is involved in the research, design, production, and sale of battery packs and systems, and lithium batteries. The company's products are used in various applications, such as electric toys, power tools, portable computers and other electronics, medical devices, and other consumer products. It serves in Mainland China, Asia, Europe, North America, South America, Africa, and internationally. The company was formerly known as Hong Kong Highpower Technology, Inc. and changed its name to Highpower International, Inc. in October 2010. Highpower International, Inc. was founded in 2001 and is headquartered in Shenzhen, the People's Republic of China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Li PingDirectorNov 28Sale4.4310,50046,51215,000Nov 30 06:57 PM
LI WEN LIANGDirectorNov 01Sale5.2965,000343,9481,501,117Nov 02 08:46 PM
LI WEN LIANGDirectorOct 31Sale5.793,37019,5171,566,117Nov 02 08:46 PM
LI WEN LIANGDirectorOct 30Sale5.7733,225191,6191,569,487Oct 30 08:32 PM
LI WEN LIANGDirectorOct 27Sale5.758,88151,0711,602,712Oct 30 08:32 PM
LI WEN LIANGDirectorOct 26Sale5.7738,152220,0231,611,593Oct 30 08:32 PM
LI WEN LIANGDirectorOct 25Sale5.506,43335,3821,649,745Oct 30 08:32 PM
LI WEN LIANGDirectorOct 13Sale5.524,07022,4851,656,178Oct 17 07:04 PM
LI WEN LIANGDirectorOct 11Sale5.5289,497494,3901,660,248Oct 12 06:46 PM
LI WEN LIANGDirectorOct 10Sale5.2883,918442,9021,749,745Oct 12 06:46 PM
LI WEN LIANGDirectorOct 06Sale5.257,10737,3121,833,663Oct 10 05:07 PM
LI WEN LIANGDirectorOct 05Sale5.0166,699333,9221,840,770Oct 10 05:07 PM
LI WEN LIANGDirectorSep 21Sale5.251,8009,4501,887,469Sep 25 09:06 PM
LI WEN LIANGDirectorSep 20Sale5.1183,152424,5661,889,269Sep 20 07:14 PM
LI WEN LIANGDirectorSep 19Sale5.04117,224590,7621,972,421Sep 20 07:14 PM
LI WEN LIANGDirectorSep 18Sale5.001005002,089,645Sep 20 07:14 PM